Pharmaceutical Technology on MSN
GSK targets Syndivia’s prostate cancer ADC in £268m buy
GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...
The team at Edge Physical Therapy: Dr. Joanne Thomas, PT, DPT; Ashley Roessler, PTA, CPT; Patient Care Coordinator Christine Bare; Dr. Erica Crafts, DPT; and Dr. Chad Crafts, DPT, MS, CSCS, PES, CES.
The AI features in web browsers, particularly in browsers like Edge, are designed to automate repetitive or monotonous tasks. Follow the complete guide to know how and where to use these AI features.
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...
TUESDAY, Oct. 14, 2025 (HealthDay News) — Former President Joe Biden is now receiving radiation and hormone therapy to treat ...
Even while warning about national security and human rights abuse, the U.S. government across five Republican and Democratic ...
You can tell a lot about a person by how they make a peanut butter and jelly sandwich. Unfortunately, one part of the process ...
Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
A massive internet outage stemming from errors in Amazon cloud services on Monday morning demonstrated just how many people ...
The Healthy @Reader's Digest on MSN
New Prostate Cancer Treatment Options You Should Know About, From a Urologic Surgeon
A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...
Prof. Pat Price calls for global investment in radiotherapy to ensure equitable access to life-saving, precision cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results